Healthtech Startups

Neurosom develops a wearable sleep therapy device called Sleep WISP that uses EEG monitoring and AI-driven electrical stimulation to improve deep sleep and reduce dementia risk. The system is designed for at-home use and targets patients seeking cognitive health and disease prevention.

1 investor

NeuroTrainer offers a cognitive training system using virtual reality and neuroscience to improve mental performance skills for athletes and students. The platform is designed for coaches and educators to elevate cognitive abilities including focus, decision-making, reaction time, and situational awareness.

1 investor

1 investor

NeuroTx develops AI-powered electroceutical and neurotechnology solutions that use neural decoding and non-invasive vagus nerve stimulation to support sleep quality, cognitive function, and metabolic health. The company integrates wearable devices, mobile applications, and machine learning to deliver personalized bio-signal-based interventions for consumers and patients.

1 investor

1 investor

NeuroVigil develops portable, single-channel EEG brain-monitoring technology and analysis software for neurological research, disease diagnosis, and pharmaceutical clinical trials. Its systems are used to monitor sleep and brain activity for conditions such as ALS, Alzheimer's, and Parkinson's, serving researchers, drug developers, and patients.

1 investor

NeuroVirt provides mixed reality therapy software for stroke and neurorehabilitation, offering gamified exercises for upper and lower limb recovery in clinical and home settings with real-time motion tracking and clinician dashboards.

1 investor

Neurum uses digital behavioral data and machine learning to generate mental-health indicators and individualized care pathways. It is sold to employers and care providers, who receive risk forecasts, intervention prompts, and analytics for tracking changes in workforce wellbeing over time.

1 investor

Neutrolis is a clinical-stage biotech developing first-in-class therapies that degrade neutrophil extracellular traps (NETs) to address the root cause of autoimmune and inflammatory diseases such as lupus and rheumatoid arthritis. Its approach targets the process of NETosis to treat these disorders without relying on immunosuppression.

1 investor

Neutun is a Canadian health technology company that develops software for monitoring epileptic seizures using commercially available wearable devices. Its application handles continuous passive monitoring, medication reminders, alerts, and progress logging. The tool is aimed at people managing epilepsy and other chronic or acute conditions who need a record of their events.

1 investor

Neuvasq Biotechnologies is a biotech spin-off from the Université libre de Bruxelles developing therapies that target the Gpr124/Reck signaling complex to repair the blood-brain and blood-CNS barriers in neurological and cerebrovascular disorders. The company translates research on brain vasculature and the blood-brain barrier into drug development programs.

1 investor

NeuWave Medical develops the NeuWave Microwave Ablation System, a device used by healthcare professionals to ablate soft tissue, including non-resectable liver tumors, in percutaneous, open surgical, and laparoscopic settings. The system includes a probe portfolio and ABLATE-IQ software for margin confirmation, and is marketed for use in the United States; the company is a wholly owned subsidiary of Quantum Surgical, Inc.

1 investor

NEVAP develops airway management devices, including a subglottic suction endotracheal tube designed to drain tracheal secretions and reduce the risk of ventilator-associated and other pneumonias in ventilated patients. Its products are aimed at clinical settings such as the ICU, operating room, and emergency department.

1 investor

nevisQ makes the nevisCura bed sensor, a fall-prevention device that mounts on care beds and detects when a resident is getting out of bed, then alerts nursing staff through existing nurse-call, telephone, or emergency-call systems. It serves care homes, senior residences, and hospitals across Germany, Austria, Switzerland, Belgium, Luxembourg, and Spain.

1 investor

New Incentives provides conditional cash transfers to caregivers in Nigeria to incentivize childhood vaccination and other health behaviors. The organization operates in clinics across northern Nigeria to improve vaccination coverage and health outcomes for infants and underserved populations.

1 investor

New Life Minds develops technology combining healthcare, life sciences, synthetic biology, and machine learning, with a stated focus on advancing brain evolution.

1 investor

An independent nonprofit academic research institution that convenes talent from academic, research, and medical institutions to advance collaborative genomic research and accelerate discoveries in the genetic basis of disease for clinical diagnosis and treatment.

1 investor

New Zealand Clinical Research (NZCR) is a clinical trials and medical research organization that conducts early-phase and later-phase clinical research for pharmaceutical, biotech, and contract research organizations. With over 35 years of experience and multiple facilities across New Zealand, the organization specializes in testing new medicines and treatments across various therapeutic areas including gene therapy, hepatology, and vaccines.

1 investor

New Day Healthcare invests in home care and hospice businesses, providing capital and operational expertise from seasoned industry leaders to support patient-centered outcomes. The firm partners with home care operators who share its values of clinical quality, financial responsibility, and mission-driven stewardship.

1 investor

NewGen Health is developing an at-home care management platform, including a SmartCup device that analyzes urine samples and vital signs at home, with results and trends shared with patients' care teams via cloud storage and EMR integration. It targets monitoring for chronic kidney disease, expectant mothers, and diabetes/cardio-metabolic care, with a stated focus on health equity and accessible care.

1 investor

New Look Vision Group is a Canadian eye care company operating a network of optical retail brands and offering prescription eyewear, including online purchasing of prescription glasses. It has grown through acquisitions of optical retailers across Canada and the United States.

1 investor

Newronika is a spin-off of Italian research institutions Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and the University of Milan that develops adaptive deep brain stimulation (αDBS) technology which responds to brain activity in real time. Its neuromodulation systems target Parkinson's disease and are being studied for a broader range of brain disorders, serving clinicians and patients.

1 investor

Newton is an innovation company that develops therapeutic optical lenses for treating eye-related conditions like headaches, motion sickness, and neck pain caused by eye misalignment. The company serves optometrists and patients across North America and Europe in the healthcare and optical devices sector.

1 investor

Newton builds a unified phone system platform for dental practices, integrating AI receptionist capabilities with traditional staff workflows to replace fragmented communication tools. The platform serves dental offices looking to streamline multi-location call management and operations.

1 investor